Schindler Matthias, Spycher Ben D, Ammann Roland A, Ansari Marc, Michel Gisela, Kuehni Claudia E
Institute of Social and Preventive Medicine (ISPM), University of Bern, Finkenhubelweg 11, Bern, CH-3012, Switzerland.
Department of Pediatrics, University of Bern, Freiburgstrasse 4, Bern, CH-3010, Switzerland.
Int J Cancer. 2016 Jul 15;139(2):322-33. doi: 10.1002/ijc.30080. Epub 2016 Mar 30.
Survivors of childhood cancer have a higher mortality than the general population. We describe cause-specific long-term mortality in a population-based cohort of childhood cancer survivors. We included all children diagnosed with cancer in Switzerland (1976-2007) at age 0-14 years, who survived ≥5 years after diagnosis and followed survivors until December 31, 2012. We obtained causes of death (COD) from the Swiss mortality statistics and used data from the Swiss general population to calculate age-, calendar year-, and sex-standardized mortality ratios (SMR), and absolute excess risks (AER) for different COD, by Poisson regression. We included 3,965 survivors and 49,704 person years at risk. Of these, 246 (6.2%) died, which was 11 times higher than expected (SMR 11.0). Mortality was particularly high for diseases of the respiratory (SMR 14.8) and circulatory system (SMR 12.7), and for second cancers (SMR 11.6). The pattern of cause-specific mortality differed by primary cancer diagnosis, and changed with time since diagnosis. In the first 10 years after 5-year survival, 78.9% of excess deaths were caused by recurrence of the original cancer (AER 46.1). Twenty-five years after diagnosis, only 36.5% (AER 9.1) were caused by recurrence, 21.3% by second cancers (AER 5.3) and 33.3% by circulatory diseases (AER 8.3). Our study confirms an elevated mortality in survivors of childhood cancer for at least 30 years after diagnosis with an increased proportion of deaths caused by late toxicities of the treatment. The results underline the importance of clinical follow-up continuing years after the end of treatment for childhood cancer.
儿童癌症幸存者的死亡率高于普通人群。我们描述了一个基于人群的儿童癌症幸存者队列中特定病因的长期死亡率。我们纳入了瑞士所有在0至14岁时被诊断患有癌症且诊断后存活≥5年的儿童,并对幸存者进行随访直至2012年12月31日。我们从瑞士死亡率统计数据中获取死亡原因(COD),并使用瑞士普通人群的数据通过泊松回归计算不同COD的年龄、日历年和性别标准化死亡率(SMR)以及绝对超额风险(AER)。我们纳入了3965名幸存者,共49704人年的风险期。其中,246人(6.2%)死亡,这比预期高出11倍(SMR 11.0)。呼吸系统疾病(SMR 14.8)、循环系统疾病(SMR 12.7)以及二次癌症(SMR 11.6)的死亡率尤其高。特定病因死亡率的模式因原发性癌症诊断而异,并随诊断后的时间而变化。在5年存活后的前10年,78.9%的超额死亡是由原发癌症复发导致的(AER 46.1)。诊断后25年,只有36.5%(AER 9.1)是由复发导致的,21.3%是由二次癌症导致的(AER 5.3),33.3%是由循环系统疾病导致的(AER 8.3)。我们的研究证实,儿童癌症幸存者在诊断后至少30年内死亡率升高,且治疗后期毒性导致的死亡比例增加。结果强调了儿童癌症治疗结束后多年持续进行临床随访的重要性。